SCHEMBL196352

SCHEMBL196352

CCOC(=O)C(F)(F)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 2/20 0.41
HIF1A Q16665 1/20 0.41
PKM P14618 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX15 P16050 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
SOAT1 P35610 1/20 0.40
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29229720 0.93 HDAC4 (0.40) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL4392350 0.90 ALDH1A1 (0.48) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL198069 0.86 ALDH1A1 (0.40) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL31053921 0.86 ALDH1A1 (0.40) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL4007477 0.85 ALDH1A1 (0.43) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL27186828 0.85 ALDH1A1 (0.43) ALDH1A1POLBNPSR1LMNAHSD17B10
Ammonia Solution, Strong SCHEMBL27753007 0.84 POLB (0.39) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL2050077 0.84 CA1 (0.43) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL8165793 0.83 ALDH1A1 (0.42) ALDH1A1POLBNPSR1LMNAHSD17B10
SCHEMBL8166839 0.83 ALDH1A1 (0.42) ALDH1A1POLBNPSR1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122073257-A Sodium ion battery electrolyte and preparation method and application thereof 中国科学院大连化学物理研究所 2026-05-22 CN claimed
CN-122068120-A Low-temperature electrolyte of lithium ion battery and preparation method thereof 国钠能源科技(河北)有限公司 2026-05-19 CN claimed
US-20250346622-A1 NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-11-13 US claimed
EP-4585601-A1 NOVEL OLIGOSACCHARIDE, PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, PRODUCTION METHOD FOR NOVEL OLIGOSACCHARIDE, AND PRODUCTION METHOD FOR PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE Daiichi Sankyo Company, Limited (JP) 2025-07-16 EP claimed
CN-120079266-A Preparation process of organic composite material with ultrahigh salt resistance 南京工业大学 2025-06-03 CN claimed
WO-2025091685-A1 FLUORINATED LIQUID COMPOSITION AND USE THEREOF 深圳市鸿富诚新材料股份有限公司 2025-05-08 WO claimed
CN-119920979-A Electrolyte, preparation method thereof and battery 浙江金羽新能源科技有限公司 2025-05-02 CN claimed
CN-119009119-A Sodium ion battery electrolyte and sodium ion battery 福州大学 2024-11-22 CN claimed
US-20240363910-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE CONTAINING SAME NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-31 US claimed
EP-4424717-A1 NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE Daiichi Sankyo Company, Limited (JP) 2024-09-04 EP claimed
US-7598413-B2 Process for producing fluorine-containing alkylsulfonylaminoethyl α-substituted acrylate CENTRAL GLASS COMPANY, LIMITED (JP) 2009-10-06 US claimed
US-20090069595-A1 Process for Producing Fluorine-Containing Alkylsulfonylaminoethyl Alpha-Substituted Acrylate CENTRAL GLASS COMPANY, LIMITED (JP) 2009-03-12 US claimed
US-20030194378-A1 Novel aerosol formulation containing a polar fluorinated molecule ASTRAZENECA AB (SE) 2003-10-16 US claimed
EP-1303258-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE AstraZeneca AB (SE) 2003-04-23 EP claimed
EP-0828717-B1 METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES SEARLE & CO (US) 2002-09-04 EP claimed
WO-2002003958-A1 NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE ASTRAZENECA AB (SE) 2002-01-17 WO claimed
US-5910597-A Process for preparing 3-haloalkyl-1H-pyrazoles G.D. SEARLE & CO. (US) 1999-06-08 US claimed
US-5892053-A Process for preparing 3-haloalkyl-1H-pyrazoles G. D. SEARLE & CO. (US) 1999-04-06 US claimed
EP-0828717-A1 METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES G.D. SEARLE & CO. (US) 1998-03-18 EP claimed
WO-1996037476-A1 METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES G.D. SEARLE & CO. (US) 1996-11-28 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346622-A1 NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE FUT6, FUT5, ST3GAL3 ALDH1A1 450/4885POLB 4505/4885NPSR1 2685/4885
US-20090069595-A1 Process for Producing Fluorine-Containing Alkylsulfonylaminoethyl Alpha-Substituted Acrylate AFF1, AFF2, AFF4 ALDH1A1 3874/4885POLB 483/4885NPSR1 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.